NASDAQ
INBS

Intelligent Bio Solutions Inc.

Medical Devices
Healthcare

Prices are adjusted according to historical splits.

Intelligent Bio Solutions Inc. Stock Price

Vitals

Today's Low:
$1.47
Today's High:
$1.676
Open Price:
$1.57
52W Low:
$1.38
52W High:
$28.8
Prev. Close:
$1.58
Volume:
60664

Company Statistics

Market Cap.:
$4.12 million
Book Value:
1.631
Revenue TTM:
$1.26 million
Operating Margin TTM:
-671.24%
Gross Profit TTM:
$326668
Profit Margin:
0%
Return on Assets TTM:
-46.44%
Return on Equity TTM:
-208.44%

Company Profile

Intelligent Bio Solutions Inc. had its IPO on 2020-12-23 under the ticker symbol INBS.

The company operates in the Healthcare sector and Medical Devices industry. Intelligent Bio Solutions Inc. has a staff strength of 51 employees.

Stock update

Shares of Intelligent Bio Solutions Inc. opened at $1.57 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $1.47 - $1.68, and closed at $1.5.

This is a -5.06% slip from the previous day's closing price.

A total volume of 60,664 shares were traded at the close of the day’s session.

In the last one week, shares of Intelligent Bio Solutions Inc. have slipped by -15.25%.

Intelligent Bio Solutions Inc.'s Key Ratios

Intelligent Bio Solutions Inc. has a market cap of $4.12 million, indicating a price to book ratio of 1.2153 and a price to sales ratio of 8.5798.

In the last 12-months Intelligent Bio Solutions Inc.’s revenue was $1.26 million with a gross profit of $326668 and an EBITDA of $-7622082. The EBITDA ratio measures Intelligent Bio Solutions Inc.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Intelligent Bio Solutions Inc.’s operating margin was -671.24% while its return on assets stood at -46.44% with a return of equity of -208.44%.

In Q2, Intelligent Bio Solutions Inc.’s quarterly earnings growth was a positive 0% while revenue growth was a negative 95.8%.

Intelligent Bio Solutions Inc.’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-10.64 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Intelligent Bio Solutions Inc.’s profitability.

Intelligent Bio Solutions Inc. stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -3.8487. Its price to sales ratio in the trailing 12-months stood at 8.5798.

Intelligent Bio Solutions Inc. stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$10.35 million
Total Liabilities
$5.88 million
Operating Cash Flow
$0
Capital Expenditure
$0
Dividend Payout Ratio
0%

Intelligent Bio Solutions Inc. ended 2024 with $10.35 million in total assets and $0 in total liabilities. Its intangible assets were valued at $10.35 million while shareholder equity stood at $3.80 million.

Intelligent Bio Solutions Inc. ended 2024 with $0 in deferred long-term liabilities, $5.88 million in other current liabilities, 23304.00 in common stock, $-41807573.00 in retained earnings and $0 in goodwill. Its cash balance stood at $1.54 million and cash and short-term investments were $1.54 million. The company’s total short-term debt was $576,658 while long-term debt stood at $402862.00.

Intelligent Bio Solutions Inc.’s total current assets stands at $3.86 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $833164.00 compared to accounts payable of $1.20 million and inventory worth $979907.00.

In 2024, Intelligent Bio Solutions Inc.'s operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Intelligent Bio Solutions Inc. paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$1.5
52-Week High
$28.8
52-Week Low
$1.38
Analyst Target Price
$13.05

Intelligent Bio Solutions Inc. stock is currently trading at $1.5 per share. It touched a 52-week high of $28.8 and a 52-week low of $28.8. Analysts tracking the stock have a 12-month average target price of $13.05.

Its 50-day moving average was $2.05 and 200-day moving average was $4.61 The short ratio stood at 1.98 indicating a short percent outstanding of 0%.

Around 2454.7% of the company’s stock are held by insiders while 970.8% are held by institutions.

Frequently Asked Questions About Intelligent Bio Solutions Inc.

The stock symbol (also called stock or share ticker) of Intelligent Bio Solutions Inc. is INBS

The IPO of Intelligent Bio Solutions Inc. took place on 2020-12-23

Similar Industry Stocks (Medical Devices)

Last Price
Chg
Chg%
$2.91
0.09
+3.19%
KonaTel Inc (KTEL)
$0.8
-0.01
-1.11%
$6.58
0.04
+0.61%
$52.99
0
0%
CFOAM Limited (CFFMF)
$0
0
+30%
$2.77
0.02
+0.73%
$581.85
-82.2
-12.38%
$6.57
0.08
+1.23%
$0.32
0.12
+61.5%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

Address

142 West 57th Street, New York, NY, United States, 10019